A prospective cohort study of patients with peripheral T-cell lymphoma in the United States-Reference-Cited by-同舟云学术

A prospective cohort study of patients with peripheral T-cell lymphoma in the United States

Published:2016-12-02 Issue:7 Volume:123 Page:1174-1183
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Carson Kenneth R.¹²,Horwitz Steven M.³,Pinter-Brown Lauren C.⁴,Rosen Steven T.⁵,Pro Barbara⁶,Hsi Eric D.⁷,Federico Massimo⁸,Gisselbrecht Christian⁹,Schwartz Marc¹⁰,Bellm Lisa A.¹⁰,Acosta Mark A.¹¹,Shustov Andrei R.¹²,Advani Ranjana H.¹³,Feldman Tatyana A.¹⁴,Lechowicz Mary Jo¹⁵,Smith Sonali M.¹⁶,Lansigan Frederick¹⁷,Tulpule Anil¹⁸,Craig Michael D.¹⁹,Greer John P.²⁰,Kahl Brad S.²,Leach Joseph W.²¹,Morganstein Neil²²,Casulo Carla²³,Park Steven I.²⁴,Foss Francine M.²⁵

Affiliation:

1. Research Service, St Louis Veterans Affairs Medical Center; St. Louis Missouri

2. Department of Medical Oncology, Division of Oncology; Washington University School of Medicine; St. Louis Missouri

3. Department of Medical Oncology; Memorial Sloan-Kettering Cancer Center; New York New York

4. Department of Medicine; University of California at Irvine; Irvine California

5. Provost and Chief Scientific Officer; Department of Hematology & Hematopoietic Cell Transplantation; City of Hope, Duarte California

6. Department of Medicine; Robert H. Lurie Comprehensive Cancer Center, Northwestern University; Chicago Illinois

7. Department of Laboratory Medicine; Cleveland Clinic; Cleveland Ohio

8. Department of Diagnostic, Clinical and Public Health Medicine; University of Modena and Reggio Emilia; Modena Italy

9. Department of Hematology-Oncology; Hôpital Saint Louis; Paris France

10. MedNet Solutions; Minnetonka Minnesota

11. Research and Development; Spectrum Pharmaceuticals Inc; Irvine California

12. Department of Medicine; Fred Hutchinson Cancer Research Center; Seattle Washington

13. Department of Medicine; Stanford University Medical Center; Stanford California

14. Department of Hematology/Oncology; John Theurer Cancer Center, Hackensack University Medical Center; Hackensack New Jersey

15. Department of Hematology and Oncology; Emory University; Atlanta Georgia

16. Department of Medicine; University of Chicago; Chicago Illinois

17. Department of Medicine; Dartmouth Hitchcock Medical Center; Hanover New Hampshire

18. Department of Medicine; University of Southern California; Los Angeles California

19. Department of Medicine; West Virginia University; Morgantown West Virginia

20. Department of Hematology; Vanderbilt University; Nashville Tennessee

21. Minnesota Oncology; Virginia Piper Cancer Institute; Minneapolis Minnesota

22. Overlook Medical Center; Summit New Jersey

23. Department of Medicine; University of Rochester; Rochester New York

24. Department of Internal Medicine; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Chapel Hill North Carolina

25. Department of Medical Oncology; Yale University; New Haven Connecticut

Funder

Spectrum Pharmaceuticals

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project;Blood,1997

2. Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification;Ascani;Ann Oncol,1997

3. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997;Harris;J Clin Oncol,1999

4. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: pathology findings and clinical outcomes;Vose;J Clin Oncol,2008

5. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies;Agostinelli;J Clin Pathol,2008

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Etoposide addition and brentuximab vedotin consolidation in first-line treatment of CD30-positive peripheral T-cell lymphoma: can we improve BV–CHP?;The Lancet Haematology;2024-09

2. Next Questions in Peripheral T-Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01

4. Prognostic Utility of a Novel Prognostic Model Consisting of Age, CRP, Ki67, and POD24 in Patients with Angioimmunoblastic T-Cell Lymphoma;Indian Journal of Hematology and Blood Transfusion;2024-04-12

5. Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application;Molecular Cancer;2024-02-17